Don't Eat the Marshmallow! 4 Tips for Financial Self-Control
Get the Lead Out: Lipsticks That Won't Hurt Your Pocketbook Or Your Health
$600 Million Powerball: 1 Winning Ticket Sold in Fla.
GM Shares Top Level Not Seen Since 2011
NASDAQ: ATHX
Sabby reports 6.9% passive stake in Athersys
Athersys files to sell 17M shares of common stock
Athersys Wraps Up MultiStem Enrollment
Athersys price target raised to $6 from $3 at Maxim
Athersys (ATHX) Pops Higher on Strong MultiStem Data in Treating MS
Athersys Presents Research Progress in Its Multiple Sclerosis Program
Orbimed lowers stake in Athersys to 3.48% from 5.56%
Athersys reports on progress in Phase 2 study of MultiStem for ischemic stroke
Athersys Reports on Progress in Phase 2 Study of MultiStem for Ischemic Stroke
Can Stem Cells Regenerate Your Portfolio? Stephen Dunn Says Yes